ARGX Q2 2025 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$46B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$948M+5.1% YoY

Gross Profit

$837M88.3% margin

Operating Income

$201M21.2% margin

Net Income

$245M25.9% margin

EPS (Diluted)

$6.37

QoQ Revenue Growth

+19.9%

Cash Flow

Operating Cash Flow

$438M

Free Cash Flow

$433M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$1.1B

Stockholders' Equity

$6.1B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$948M	$902M	+5.1%
Gross Profit	$837M	$1.3B	-34.7%
Operating Income	$201M	-$139M	+244.8%
Net Income	$245M	-$33M	+854.2%